Comparison of follow-up characteristics among the RCIR, RIR, RCR and NRR groups
| Characteristic | RCIR n=37 | RIR n=179 | RCR n=93 | NRR n=502 | P value |
| Time from stenting to clinical follow-up (months), median (IQR) | 70.2 (38.6–89.5) | 59.9 (35.3–82.4) | 59.0 (38.0–73.7) | 51.4 (37.1–77.8) | 0.380 |
| Time from stenting to imaging follow-up (months), median (IQR) | 9.9 (6.3–12.6) | 12.2 (6.8–23.5) | 12.0 (6.3–15.6) | 11.6 (6.2–18.9) | 0.332 |
| Systolic blood pressure at follow-up | |||||
| Number of evaluated, n (%) | 35 (94.6%) | 168 (93.9%) | 84 (90.3%) | 474 (94.4%) | 0.561 |
| Number of well controlled, n (%)* | 26 (74.3%) | 133 (79.2%) | 65 (77.4%) | 367 (77.4%) | 0.926 |
| LDL-C | |||||
| Number of evaluated, n (%) | 15 (40.5%) | 89 (49.7%) | 41 (44.1%) | 243 (48.2%) | 0.661 |
| Level (mmol/L), median (IQR) | 2.31 (1.81–2.67) | 1.69 (1.42–1.98) | 2.08 (1.65–2.55) | 1.65 (1.34–1.97) | <0.001 |
| Time from stenting to LDL-C (months), median (IQR) | 10.9 (3.8–14.8) | 12.4 (5.6–23.7) | 9.8 (3.3–20.1) | 11.7 (4.4–18.6) | 0.491 |
*Well-controlled systolic blood pressure at follow-up was defined as systolic blood pressure <140 mm Hg (or <130 mm Hg in patients with diabetes mellitus).
LDL-C, low-density lipoprotein cholesterol; NRR, no residual risk; RCIR, residual cholesterol inflammatory risk; RCR, residual cholesterol risk; RIR, residual inflammatory risk.